Glaxosmithkline Export Limited, Brentford - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

niquitin fresh mint 2mg medicated chewing gum

glaxosmithkline consumer healthcare (ireland) limited - nicotine - medicated chewing gum - 2mg - drugs used in nicotine dependence - it m is used for the treatment of tobacco dependence by relief of nicotine withdrawal symptoms including cravings during a quit attempt

Ireland - English - HPRA (Health Products Regulatory Authority)

niquitin fresh mint 4mg medicated chewing gum

glaxosmithkline consumer healthcare (ireland) limited - nicotine - medicated chewing gum - 4mg - drugs used in nicotine dependence - it is used for the treatment of tobacco dependence by relief of nicotine withdrawal symptoms including cravings during a quit attemp

New Zealand - English - Medsafe (Medicines Safety Authority)

fluarix tetra

glaxosmithkline nz limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/switzerland/8060/2017 (h3n2) like strain 15ug (a/brisbane/1/2018, nymc x-311); influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a (victoria lineage)); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type (yamagata lineage)) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/switzerland/8060/2017 (h3n2) like strain 15ug (a/brisbane/1/2018, nymc x-311) influenza virus b/colorado/06/2017 - like strain 15ug (b/maryland/15/2016, nymc bx-69a (victoria lineage)) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type (yamagata lineage)) excipient: d-alpha-tocopheryl acid succinate dibasic sodium phosphate dodecahydrate magnesium chloride hexahydrate monobasic potassium phosphate octoxinol polysorbate 80 potassium chloride sodium chloride water for injection - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine. the use of fluarix tetra should be based on official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

nucala

glaxosmithkline nz limited - mepolizumab 144mg ((100 mg/ml after reconstitution with 1.2 ml of wfi, delivers 1 ml)) - powder for injection - 100 mg/ml - active: mepolizumab 144mg ((100 mg/ml after reconstitution with 1.2 ml of wfi, delivers 1 ml)) excipient: dibasic sodium phosphate heptahydrate hydrochloric acid polysorbate 80 sucrose - nucala is indicated as an add-on treatment for severe eosinophilic asthma in patients aged 12 years and over.